Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363120210340010035
Korean Journal of Pain
2021 Volume.34 No. 1 p.35 ~ p.46
Antinociceptive effects of oleuropein in experimental models of neuropathic pain in male rats
Chen Huayong

Ma Dandan
Zhang Huapeng
Tang Yanhong
Wang Jun
Li Renhu
Wen Wen
Zhang Yi
Abstract
Background: The present investigation explored the therapeutic actions of oleuropein along with the possible signaling pathway involved in attenuating neuropathic pain in chronic constriction injury (CCI) and vincristine-induced neuropathic pain in male rats.

Methods: Four loose ligatures were placed around the sciatic nerve to induce CCI, and vincristine (50 ¥ìg/kg) was injected for 10 days to develop neuropathic pain. The development of cold allodynia, mechanical allodynia, and mechanical hyperalgesia was assessed using different pain-related behavioral tests. The levels of H2S, cystathionine-¥ã-lyase (CSE), cystathionine-¥â-synthase (CBS), orexin, and nuclear factor erythroid-2-related factor 2 (Nrf2) were measured in the sciatic nerve.

Results: Treatment with oleuropein for 14 days led to significant amelioration of behavioral manifestations of neuropathic pain in two pain models. Moreover, oleuropein restored both CCI and vincristine-induced decreases in H2S, CSE, CBS, orexin, and Nrf2 levels. Co-administration of suvorexant, an orexin receptor antagonist, significantly counteracted the pain-attenuating actions of oleuropein and Nrf2 levels without modulating H2S, CSE and CBS.

Conclusions: Oleuropein has therapeutic potential to attenuate the pain manifestations in CCI and vincristine-induced neuropathic pain, possibly by restoring the CSE, CBS, and H2S, which may subsequently increase the expression of orexin and Nrf2 to ameliorate behavioral manifestations of pain.
KEYWORD
Hydrogen Sulfide, Hyperalgesia, Neuralgia, Neuropeptides, NF-E2-Related Factor 2, Nociception, Orexins, Orexin Receptor Antagonists, Polyphenols, Vincristine
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø